Novavax, Inc.: Novavax to Participate in the 4th Annual Guggenheim Boston Healthcare Conference

GAITHERSBURG, Md., 2016-12-06 22:05 CET (GLOBE NEWSWIRE) -- Novavax, Inc.,
(Nasdaq:NVAX) today announced the Company will participate in the 4th Annual
Guggenheim Boston Healthcare Conference.

Conference details are as follows:

Date: Tuesday, December 13, 2016
Location: Intercontinental Boston Hotel, Boston, MA

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to
delivering novel products to prevent a broad range of infectious diseases.
Our recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the
foundation for groundbreaking innovation that improves global health through
safe and effective vaccines. Additional information about Novavax is
available on the Company's website, novavax.com.

Contact:

Novavax, Inc.

Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer

Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations

ir@novavax.com
240-268-2000

Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.

david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271

---------------------------------------
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novavax, Inc. via Globenewswire